Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 28 | 31 | +3 |
| Shares | 11.3M | 11.4M | +86.1K (+0.8%) |
| Value | $63.2M | $92.1M | +$28.9M (+45.8%) |
New holders (7)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 176,820 | $1.43M | 0.31% |
| Tamarack Advisers, LP | 175,000 | $1.42M | 0.84% |
| Jefferies Group LLC | 34,539 | $279.8K | 0.01% |
| Citadel Advisors LLC | 15,676 | $127.0K | 0.00% |
| Group One Trading, L.P. | 14,924 | $121.0K | 0.00% |
| Jane Street Group, LLC | 14,507 | $118.0K | 0.00% |
| Cutler Group LP | 139 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 49,075 | $277.0K |
| Goldman Sachs Group Inc | 10,029 | $56.0K |
| Simplex Trading, LLC | 2,177 | $12.0K |
| Toronto Dominion Bank | 61 | $0 |